<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" type="text/css" href="css/style-manual.css">
    <link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
    <script src="js/script.js"></script>
</head>
<body>
<!--Filodox-------------------------------------------------------->
<div class="bodyDiv" id="idFilodox">
    <div class="w3-container w3-center w3-animate-left">
        <h2 class="mango">Filodox</h2>
    </div>
Product Orientation & Presentation:<br>
<table class="table1">
 <tr>
    <th>Brand Name:</th>
    <th>Filodox</th>
  </tr>

  <tr>
 
    <td>Generic & Strength:</td>
	<td>Doxofylline- 200mg, 400mg, 400mg SR, 100mg/5ml</td>
    
  </tr>
  
  <tr>
    <td>Dosage Form:</td>
    <td>Tablet: Filodox 200<br>
	Tablet: Filodox 400<br>
	SR Tablet: Filodox 400<br>
	Syp: Filodox 100mg/5ml</td>
    
  </tr>
	 
  <tr>
    <td>Therapeutic Class:</td>
	<td>Anti-asthmatic & COPD</td>
    
    </tr>

   
  </tr>
	 
  <tr>
    <td>Sub Therapeutic class: </td>
	<td></td>
    
    </tr>
		
  
  <tr>
    <td>Commercial Pack:</td>
	<td>Filodox 200: 6×10's<br>
	Filodox 400: 5×10's<br>
	Filodox 400: 5×10's<br>
	Filodox 100mg/5ml: 100ml
	</td>
    
  </tr>
	 
   <tr>
    <td>Price (TP):</td>
    <td> 
	Filodox 200: <br>
	Filodox 400: <br>
	Filodox 400: <br>
	Filodox 100ml: 
	</td>
	
   </tr>	
	 
   <tr>
 
    <td>Flavour </td>
    <td>Palatable syrup with orange & pineapple flavor</td>
	 
  </tr>
  
  <tr>
 
    <td>Indication </td>
    <td> 
	 Prophylaxis of Asthma, COPD & Exercise induced bronchoconstriction
    </td>
  </tr>
  <tr>
<td>Pregnancy: 
</td>
<td>

</td>
</tr>
<tr>
<td>Lactation: 
</td>
<td>

</td>
</tr>

  
  <tr>
 
    <td>Children: </td>
    <td>
</td>
	 
  </tr>
  
   <tr>
 
    <td>Brand Name Justification: </td>
    <td>   </td>
	 
  </tr>
  
 <tr>
<td>Dosage & Administration: 
</td>
<td>
Oral administration:<br>
COPD (Chronic Obstructive Pulmonary Disease), Reversible
airways obstruction.<br>
Adult: 400 mg twice to thrice a day. Max: 1,200 mg/day.<br><br>
Child: <12 years 6-9 mg/kg twice daily;<br>
>12 years Same as adult dose.<br>
Elderly: 200 mg twice to thrice a day.<br>

</td>
</tr>
<tr>
<td>Key Selling Points: 
</td>
<td>
&#x2022; 1. Controls asthma & COPD effectively <br>
&#x2022; 2. Ensures safety profile (Cardiac, CNS & GI) due to unique dioxolane group <br>
&#x2022; 3. Affordable Doxofylline brand in Bangladesh<br> 
&#x2022; 4. Palatable syrup with orange & pineapple flavor
</td>
</tr>
<tr>
<td>Target Doctor: 
</td>
<td>
</td>
</tr>
<tr>
<td>Side effects: 
</td>
<td>
&#x2022; 

</td>
</tr>
<tr>
<td colspan="4">
---
</td>
</tr>
</table>
<br><br>
<b>Mode of action:</b>

<table class="table2">
<thead>
<tr>
<td colspan="4">
Doxofylline
</td>
</tr>
</thead>
<tbody>
<tr>
<td>&#8681;</td>
<td>&#8681;</td>
</tr>
<tr>
<td>Bronchodilatory action<br>
Through inhibition of phosphodiesterase-4 enzyme followed by the increase of intracellular concentrations of cAMP(Cyclic adenosine monophosphate)</td>
<td>Anti-inflammatory action<br>
Through inhibition of Platelet Activating Factors (PAF) and leukotriene production</td>
</tr>
<tr>
<td>&#8681;</td>
<td>&#8681;</td>
</tr>
<tr>
<td colspan="4">
Controls the symptoms of Asthma & COPD superbly
</td>
</tr>
</tbody>
</table>
<br><br>

Disease profile:<br>
Asthma:<br>
It is a long-term inflammatory disease of the airways of the lungs. It is characterized by variable
symptoms such as wheezing, shortness of breath, chest tightness & cough.<br>

Wheezing:<br>
This is a continuous, coarse, whistling sound produced in the respiratory airways during breathing<br>

Shortness of breath:<br>
It is known medically as dyspnea - is often described as an intense tightening in the chest, air hunger, difficulty breathing, breathlessness or a feeling of suffocation.<br>

COPD:<br>
It is a chronic inflammatory lung disease that causes obstructed airflow from the lungs.
Symptoms include -breathing difficulty, cough, mucoid sputum production and wheezing. It includes chronic bronchitis & emphysema.<br>
Exercise-induced bronchoconstriction:<br>
It is the narrowing of the airways causing difficulty moving air out of the lungs during exercise or physical activity.<br>

Frequently Asked Questions (FAQ)<br>
1. Why is Filodox superb drug for asthma management?<br>
Ans: Asthma is a long term inflammatory disease. Filodox effectively inhibits phosphodiesterase enzyme
and platelet activating factor thus controls asthma effectively. Moreover, it offers better safety option
than Theophylline or Amynophylline.<br>

2. Why is Doxofylline better than Theophylline or Amynophylline?<br>
Ans: Theophylline & Aminophylline have more affinity for Adenosine A1 & A2 receptor but Doxofylline
has very less affinity for Adenosine receptor. As a result chances of side effects like palpitation,
tachycardia are very low with Doxofylline.<br>

3. Why Doxofylline is safe for heart?<br>
Ans: Doxofylline is safe for heart because it has less affinity towards Adenosine 1 and Adenosine 2
receptors thus it doesn't increase heart rate and decrease arithmetic effect.<br>

4. What are the contraindications of Doxofylline?<br>
Ans: Doxofylline is contraindicated in-<br>
&#x2022; Acute myocardial infarction Patients with hypotension<br>
&#x2022; Lactating mother<br>
&#x2022; Hypersensitivity to its component<br>
5. When Doxofylline should be taken?<br>
Ans: It should be taken at the same time each day, preferably in the evening with food.<br><br>

6. What is ACOS?<br>
Ans: "Asthma COPD Overlap Syndrome" (ACOS) has been applied to the condition in which a person has clinical feature of both asthma and COPD.<br><br>

7. Why Filodox SR is superior to conventional Doxofylline brands?<br>
Ans: Sustained Release Formulation of Filodox SR provides following benefits over conventional doxofylline brands;<br>
Once daily dosing convenience<br>
Minimizes the risk of dose missing<br>
Maintains therapeutic window for a desired period of time<br>
Improves safety of drug<br>
Affordable price<br><br>

8. Why Filodox Syrup is highly acceptable to childrens?<br>
Ans: Filodox syrup is enriched with Pineapple and Orange mixed flavor, which is highly palatable and acceptable to childrens.<br><br>

9. Write down the appropriate dosing guidelines for different strength of Filodox.<br>
Ans: Filodox 200 Tablet: Two or three times daily<br>
Filodox 400 Tablet: Two or three times daily<br>
Filodox SR Tablet: Once Daily<br>
Filodox Syrup: 6mg/kg body weight two or three times daily.<br><br>

10. How does Filodox effectively manages Asthma and COPD?<br>
Ans: Filodox works with dual mode of action;<br>
Bronchodilatory action:<br>
Through inhibition of phosphodiesterase 4 enzyme followed by the increase of intracellular concentrations of CAMP<br>
Anti-inflammatory action:<br>
Through inhibition of Platelet Activating Factors (PAF) and leukotriene production<br><br>

11. Who are the target competitors of Filodox?<br>
Ans: Doxiva (Nipro JMI), Docopa (Aristopharma) & Doxoven (Beacon), Brezofil (Incepta), Dophyline (Acme).<br><br>

12. What is Sustained Release Formulation?<br>
Ans: Sustained release dosage forms are designed to release a drug at a predetermined rate in order to maintain a constant drug concentration for a desired period of time with minimum side effects.<br><br>
</div>   
<footer>
    <p>© 2024 Md. Nurullah. All rights reserved.</p>
</footer>
<center><div class="ovalEnd">The End-Filodox</div></center><!--End Line---->
</body>
</html>